Sathijeevan Nirmalananthan
Sathijeevan Nirmalananthan was appointed in a total of 13 companies and resigned from 9 of these appointments.
Role
Director
Country Of Residence
United Kingdom
Nationality
British
Date of Birth
August 1985
Occupation
Chartered Accountant
Active
3
Resigned
9
Dissolved
1
Other
0
Total
13
Companies
| Company | Timeline | Status | |
| Glymab Therapeutics Limited Director • Chartered Accountant | 24 Jun 2025←2 Months→Current | Active | |
| Scancell Holdings Plc Director • Chartered Accountant | 14 Mar 2024←1 Year 5 Months→Current | Active | |
| Scancell Limited Director • Chartered Accountant | 14 Mar 2024←1 Year 5 Months→Current | Active | |
| SP Care Holdings Limited Director • Director | 22 Feb 2023←5 Months→31 Jul 2023 | Dissolved | |
| Duo Doc Limited Director • Director | 23 Jan 2023←6 Months→31 Jul 2023 | Dissolved | |
| PNSN Company Limited Director • Director | 16 Jan 2023←1 Year 3 Months→30 Apr 2024 | Dissolved | |
| Norse Medica Limited Director • Director | 17 Oct 2022←9 Months→31 Jul 2023 | Dissolved | |
| Prenetics Consumer Healthcare Limited Director • Director | 12 Oct 2022←9 Months→31 Jul 2023 | Dissolved | |
| Dnafit Life Sciences Limited Director • Director | 29 Sep 2022←10 Months→31 Jul 2023 | Dissolved | |
| Oxsed Limited Director • Director | 29 Sep 2022←10 Months→31 Jul 2023 | Active | |
Mutual People
- Danny Sheng Wu YeungPrenetics Emea Limited, Prenetics Consumer Healthcare Limited, Dna Sport Limited, and 4 more are mutual companies.
- Nigel James Forrester EvansScancell Limited and Scancell Holdings Plc are mutual companies.
- Dr Richard Morley GoodfellowScancell Holdings Plc and Scancell Limited are mutual companies.
- Matthew Gerard Winston FrohnScancell Holdings Plc and Scancell Limited are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
